The PBAC suggested broadening the listing of nivolumab and ipilimumab on the PBS.

PBAC suggested broadening the PBS listing of nivolumab and ipilimumab.

Leave a Reply

Your email address will not be published.

Previous Story

Maynilad Water Earnings With IPO In The Middle Of Weak Philippine Market View

Next Story

Sabah surveys: Separating feeling and reasoning

Don't Miss